Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(17%)
Results Posted
25%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
3
50%
Ph early_phase_1
1
17%
Ph phase_2
2
33%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (16.7%)
Phase 13 (50.0%)
Phase 22 (33.3%)

Trials by Status

completed467%
terminated117%
active_not_recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
active_not_recruitingphase_2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

NCT06790290
terminatedphase_2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

NCT03572062
completedearly_phase_1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

NCT03718390
completedphase_1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

NCT02426632
completedphase_1

Bioequivalence and Food Effect Study in Healthy Volunteers

NCT00495274
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06790290Phase 2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Active Not Recruiting
NCT03572062Phase 2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Terminated
NCT03718390Early Phase 1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Completed
NCT02426632Phase 1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Completed
NCT00495274Phase 1

Bioequivalence and Food Effect Study in Healthy Volunteers

Completed
NCT00548769Phase 1

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6